In The News

Attorneys Author Chambers Global Practice Guide Chapter on 2022 Life Sciences US Trends and Developments

Practices: Health Care, Intellectual Property, Mergers & Acquisitions, Private Equity, Corporate Governance & Compliance, Life Sciences Licensing, Collaborations & Joint Ventures, Capital Markets, Venture Capital & Emerging Companies , Digital Health

Life sciences partner Marc Rubenstein and associates Kyle Connors, Caroline Lawrence, Michael Stone and Mallory Ursul authored a 2022 Chambers Global Practice Guide chapter on “Life Sciences U.S. Trends and Developments.”

The authors note the COVID-19 pandemic has had a profound impact on the life sciences industry giving rise to a surge in collaborations, increased adoption in decentralized clinical trials and a shift towards supplier diversification. Many life sciences companies are more collaborative, more digital and more focused on pandemic preparedness than they would have been without the pandemic. As the pandemic turns endemic and new variants emerge, emerging trends and developments in the biotechnology, pharmaceutical, medical device and digital health sectors for the year ahead are examined in the article.

Cookie Settings